Testing effectiveness (Phase 2)Looking for participantsNCT06652048
What this trial is testing
High-dose Furmonertinib or Combined With Chemotherapy in EGFR-mutant Advanced NSCLC After Disease Progression on Third-generation EGFR-TKI
Who this might be right for
Non-Small Cell Lung Cancer
Jialei Wang 60